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1. Introduction  
Atherosclerosis continues to be the leading cause of cardiovascular disease. Atherosclerotic 
lesion progression depends on chronic inflammation in the aorta and the immune response 
is involved in this process (Galkina & Ley, 2009; Hansson & Hermansson, 2011). While it is 
now generally accepted that chronic inflammation of the arterial wall, precipitated by an 
immune response targeting modified low density lipoproteins, heat shock protein 60, ǃ2-
glycoprotein I, and other self-antigens, underlies the pathophysiology of atherosclerosis, this 
notion was met with scepticism historically. 
The term atherosclerosis was first introduced by the French surgeon and pathologist Jean 
Lobstein in 1829. Within a few years the associated cellular immune alterations in the 
arteries of atherosclerotic cadavers were described by two schools of pathology yielding two 
theories on the pathology atherosclerosis. Carl von Rokitansky proposed that initial injury 
of the aorta preceded the cellular inflammatory changes, suggesting a secondary role for 
aortic leukocytes. In contrast, Rudolf Virchow postulated an initiating role for aortic cellular 
conglomerates (Methe & Weis, 2007; Mayerl et al., 2006). However, despite these 
observations, the response-to- injury model of atherosclerosis prevailed in the literature 
until the early 1980s. In 1979, the presence of monocytes adhering to the endothelial layer of 
porcine and human atheroma was demonstarted (Gerrity & Naito, 1980). In 1980, expression 
of HLA-DR by vascular endothelial cells was reported (Hirschberg et al., 1980). It was also 
found that interferon-Ǆ (IFN-Ǆ) potently induced MHC-II expression on cultured endothelial 
cells, suggesting that T cell-derived cytokines may play an important role in the vasculature 
(Pober et al., 1983). In 1985 and 1986, the presence of HLA-DR+ cells, CD4+ and CD8+ T cells 
in carotid entarterectomy specimens was reported, further implicating that a cellular 
immune response occurs in atherosclerosis (Jonasson et al., 1985; Jonasson et al., 1986). Since 
these initial findings a plethora of recent papers have further highlighted the presence of 
multiple subsets of leukocytes in aortas, and demonstrated the importance of the immune 
system during atherogenesis. The occurrence of inflammatory cells in the aorta depends on 
the dynamics of their recruitment and possibly egress, as well as the balance between 
proliferation, survival, and apoptosis within the aorta. To date, several adhesion molecules 
and chemokines, which support subset-specific leukocyte homing into the aorta, have been 
identified, but questions concerning the role of the adventitial vasa vasorum in leukocyte 
homing, kinetics and the specific mechanisms of migration of different cell subsets including 






2. Multiple steps of the adhesion cascade 
Peripheral blood leukocytes are programmed to constitutively home to secondary lymphoid 
organs in search of possible antigens, in order to mount an appropriate immune response 
against infections. It has also been recognized that a small subset of leukocytes home into non-
lymphoid tissues as a part of constitutive homing in order to sample antigens in local tissues. 
In line with this notion, leukocytes are found within normal/non-inflamed aortas and recent 
studies have demonstrated that these cells constitutively migrate into the aorta. The migration 
of leukocytes into non-lymphoid sites where injury, infection or inflammation has occurred is 
also highly specific. To date, there are several examples of immune-mediated chronic diseases 
such as rheumatoid arthritis, Type 1 diabetes mellitus, psoriasis, and multiple sclerosis that 
have marked adhesion molecule-mediated homing of leukocytes into the site of inflammation. 
It is now appreciated that atherosclerosis-prone conditions activate aortic vascular cells, 
upregulate adhesion molecules, and chemokines; thereby supporting leukocyte homing into 
the aorta (Galkina & Ley, 2007a) – a key step in the pathology of atherosclerosis.  
2.1 Steps of the adhesion cascade 
2.1.1 Selectins and rolling 
The adhesion cascade is defined as series of overlapping and synergistic interactions among 
adhesion molecules and chemokines. There are several major steps of the leukocyte 
adhesion cascade including selectin–dependent tethering and rolling, selectin or arrest 
chemokine-dependent activation, integrin-dependent arrest, firm adhesion and diapedesis, 
which are closely interconnected and regulate cell-specific migration. The first steps of the 
adhesion cascade consist of tethering, capture, and rolling, which are initiated via selectin-
carbohydrate ligand interactions along the endothelium (McEver, 2002). L-selectin is 
expressed by all leukocytes, mediates leukocyte rolling and can also participate in secondary 
capture, defined as leukocyte capture by adherent leukocytes (reviewed in (Ley et al., 2007)). 
P- and E-selectin are expressed by the activated endothelium and serve as rolling molecules 
for most leukocytes (McEver, 2002). Activated platelets also express P-selectin. P-selecin 
binds PSGL-1 expressing neutrophils, monocytes, and lymphocytes (Ley & Kansas, 2004). E-
selectin binds PSGL-1, CD44, E-selectin ligand-1(ESL-1) on myeloid cells and CD43 on T-
helper 1 lymphocytes (reviewed in (Ley et al., 2007)). Selectins tightly control leukocyte 
rolling velocity via regulation of the rapid formation and dissociation of bonds between 
selectins and their ligands (Alon et al., 1997). L- and P-selectin support rolling at relatively 
fast velocities, while E-selectin supports leukocyte rolling at very slow velocities (Kunkel & 
Ley, 1996). Evidence suggests that selectin ligation by endothelial ligands can induce 
activation of integrins, and provide a link between rolling and the subsequent integrin-
mediated firm adhesion (Zarbock et al., 2007). 
2.1.2 Integrins, arrest chemokines, and firm adhesion 
Following the steps of tethering and rolling, leukocyte integrins initiate slowing rolling, and 
induce further firm adhesion. The integrin family consists of  and  subunits that form 
heterodimers yielding a total of 24 integrins (Hynes, 2002). All leukocytes express leukocyte 
function-associated molecule (LFA-1, CD11a/CD18, or ǂ-Lǃ2), while myeloid cells 
predominately express Mac-1. Endothelial ligands for LFA-1 and Mac-1 include intercellular 
adhesion molecule 1 (ICAM-1) and ICAM-2. The 41 (VLA-4) integrin is a member of the 4 
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subfamily and is mostly expressed on extralymphoid monocytes and on lymphocytes 
(Luster et al., 2005). Vascular cell adhesion molecule-1 (VCAM-1) (Kinashi, 2007) and the 
CS-1 peptide of fibronectin (Guan & Hynes, 1990) serve as ligands for VLA-4. VCAM-1 is 
not constitutively expressed in most tissues, but is upregulated after stimulation with TNF- 
and IL-1. Chemokines support migration via the formation of chemotactic gradients from 
emigrated leukocytes and resident tissue cells. Endothelial cells synthesize and present 
chemokines on the luminal surface. Most chemokines can be also immobilized by 
extracellular matrix components, including heparan sulfate and glycosaminoglycans, and 
presented to leukocytes (Ley et al., 2007). Several members of a specialized group of arrest 
chemokines play an essential role in integrin activation and firm adhesion.  
2.1.3 JAMs, PECAM-1, VE-Cadherin and transmigration 
Increased time of firm leukocyte adhesion reduces rolling velocities, and initiates cell 
crawling or locomotion in order to find an appropriate site for transmigration/diapedesis. 
There are two principal mechanisms of transmigration: via intercellular junctions or 
through the endothelial cell body (Carman & Springer, 2004; Shaw et al., 2004). To date, it 
is unclear which parameters preferentially affect the pathways of transmigration. CD99-
related antigen (CD99L2), endothelial cell-selective adhesion molecule (ESAM) and 
junctional adhesion molecules (JAMs) are important regulators of diapedesis. JAMs 
belong to the members of immunoglobulin superfamily, which are localized to 
intercellular junctions of polarized endothelial and epithelial cells, but are also expressed 
on circulating leukocytes and platelets (Mandell & Parkos, 2005). JAMs participate in 
homophilic and heterophilic cell interactions, and thus, support the extravasation of 
leukocytes into tissues. JAM-A binds to LFA-1, JAM-B to VLA-4, and JAM-C to Mac-1 
(Vestweber, 2007). VE-cadherin is expressed between endothelial cells and serves as a 
barrier for extravasating leukocytes in vivo (Lampugnani et al., 1992). ICAM-1 and ICAM-
2 can also participate in leukocyte transmigration through the development of the specific 
structures that surround leukocytes during transmigration (Carman & Springer, 2004), 
and/or form ring-like clusters of LFA-1 at the interface between the transmigrating 
leukocyte and endothelial junctions (Shaw et al., 2004). Platelet endothelial cell adhesion 
molecule-1 (PECAM-1) is a member of the immunoglobulin superfamily that is expressed 
on leukocytes, platelets, and interendothelial junctions. PECAM-1 promotes leukocyte 
transmigration as an adhesion molecule (Newman, 1997), but can also serve as a signaling 
receptor (Vestweber, 2007).  
3. Regulators of adhesion molecule expression in atherogenesis 
Many inflammatory factors such as multiple cytokines, 5-lipoxygenase, 12/15-lipoxygenase, 
heme oxygenase-1, paraoxonases, C-reactive protein, reactive oxygen species, advanced 
glycation end products (AGE), oxidized-LDL, and blood flow conditions (reviewed by 
(Tedgui & Mallat, 2006; Galkina & Ley, 2009), play crucial roles during atherogenesis. One 
of the many essential functions of these factors is the induction and the regulation of the 
expression of adhesion molecules and chemokines. As these factors have been reviewed in 
depth elsewhere (Galkina & 2009; Tedgui & Mallat, 2006), we will focus briefly only on 
some inflammatory molecules and conditions that have been demonstrated to affect the 






3.1 Effects of cytokines on the expression of aortic adhesion molecules and 
chemokines 
3.1.1 TNFα and the TNFα superfamily 
The pro-inflammatory effects of TNF-ǂ in atherogenesis are well established. TNF-ǂ 
upregulates a variety of adhesion proteins, including LFA-1, VCAM-1, and ICAM-1 on human 
endothelial cells in vitro (Sprague & Khalil, 2009). Cleavage, but not the membrane bound form 
of TNF-ǂ, is required for TNFǂ’s pro-atherogenic properties. Mast-cell-, M-, and neutrophil-
derived TNF-ǂ and IL-6 similarly promote the expression of several adhesion molecules, 
including VCAM-1, ICAM-1, P- and E-selectin, in endothelial cells and further support the 
adherence of neutrophils under physiological shear stress conditions (Zhang et al., 2011). 
Another member of the TNF superfamily, Lymphotoxin-ǃ (LTǃ), can similarly promote 
CXCL13 and CCL21 induction in medial smooth muscle cells (Grabner et al., 2009). In 
addition, further investigation into the mechanisms behind LTǃ-receptor mediated production 
of CXCL13 and CCL21 by smooth muscle cells revealed a synergistic interaction between TNF-
ǂ and LTǃ-ǃ mediated activation of the NF-κB pathway that led in elevated expression of 
multiple chemokines in smooth muscle cells (Lötzer, et al. 2010). 
3.1.2 The interleukin-17 family 
Recently, several studies have demonstrated the presence of Th17 and other IL-17A+ cells 
within murine and human atherosclerotic tissues (Ait-Oufella et al., 2011). Th17 and other 
IL-17A+ T cells play critical roles in the defence against extracellular bacteria and fungi, but 
also promote inflammation in multiple autoimmune disorders through the production of 
several chemokines by IL-17 receptor expressing resident epithelial, endothelial cells, and 
fibroblasts. IL-17A may similarly be involved in atherogenesis through the production of 
multiple chemokines and adhesion molecules; however, the exact role of this cytokine is 
currently contested. 
3.2 The effect of other inflammatory factors and flow conditions on the expression of 
adhesion molecules and chemokines 
3.2.1 Modified LDL 
In addition to oxLDL’s antigenic properties and its ability to induce foam cell formation 
and endothelial cell dysfunction, several studies have demonstrated that modified LDL 
may also directly affect the expression of adhesion molecules, and thereby affect the 
recruitment of leukocytes to the aorta. OxLDL can be trapped beneath the subendothelial 
matrix via heparin sulphate-dependent binding in vivo (Pillarisetti et al., 1997) and thus, 
locally affect vascular cells. OxLDL promotes P-selectin expression in activated human 
aortic endothelial cells (Gebuhrer et al., 1995), and monocyte transmigration through 
human umbilical vein endothelial cell layers (Hashimoto et al., 2007). Similarly, modified 
(Keiper et al., 2005; Parhami et al., 1993) or enzymatically degraded LDL (Klouche et al., 
1999) induces CCL2, CXCL1, ICAM-1, PECAM-1, JAM-C, P- and E-selectin in endothelial 
cells in vitro. Several studies have demonstrated that lysophosphatidylcholine 
(LysoPTdCho), a component of oxidized LDL, functions as a chemotactic factor for 
monocytes (Quinn et al. 1988), and neutrophils (Murugesan et al. 2003), both directly 
(Quinn et al. 1987), and via regulation of endothelial VCAM-1, ICAM-1 (Kume et al. 1992), 
CCL2, and IL-8 (Murugesan et al. 2003). 
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Fig. 1. Regulators of adhesion molecule expression. 
Several factors that may affect the expression of adhesion molecules during atherogenesis 
are shown. Multiple cytokines upregulate adhesion molecule expression in endothelial and 
smooth muscle cells. In addition, other pro-inflammatory conditions such as low shear 
stress, oscillatory blood flow (arrows, right), modified LDL, ROS and AGE (not shown) 
regulate endothelial and smooth muscle cell adhesion molecules. “Dec.” denotes adhesion 
molecules that have been demonstrated to be down regulated. 
3.2.2 Flow conditions 
Flow conditions at branching points of the vasculature may also affect the expression of 
adhesion molecules and account for anatomical variations in the sites of atherogenesis 
(VanderLaan et al., 2004).  Shear stress, the force that acts on the endothelium as a result of 
blood flow, plays a critical role in the development of endothelial dysfunction and 
atherosclerosis. Areas of coronary arties that exhibit low shear stress or areas where shear 
stress is oscillatory frequently contain atherosclerotic plaques (Davies et al., 2002; Pedersen 
et al., 1999). There are multiple lines of evidence indicating that the areas of low shear stress 
or oscillatory flow conditions display changes in the expression of adhesion molecules. 
Indeed, human aortic endothelial cell culture with oscillatory flow conditions in vitro 
upregulate VCAM-1 and ICAM-1 (Brooks et al., 2002). Similarly, in an in vivo model of 
oscillatory flow using a common carotid artery cast in Apoe-/- mice, several chemokines were 
upregulated in areas of low shear stress (CCL2, CXCL1, CXCL10, and CX3CL1) and 
oscillatory shear stress (CCL2, and CXCL1) (Cheng et al., 2007). Furthermore, in a study 
examining the response of endothelial cells to changes in shear stress, HAECs pre-
stimulated with TNF-ǂ and simultaneously exposed to a linear gradient of shear stress (0-16 
dyne/cm2) resulted in the upregulation of VCAM-1, E-Selectin under lower shear stress 






3.3 Soluble adhesion molecules and atherosclerosis 
Multiple studies have demonstrated that soluble adhesion molecules, including sE-Selectin, 
sP-Selectin, sL-Selectin, sVCAM-1, sICAM-1, sCD40, and sCD40L, are elevated within the 
plasma of coronary artery disease patients and are associated with the severity of stenosis, as 
well as, several atherosclerotic disease risk factors including smoking, obesity, diabetes, 
hypertension, etc (reviewed in Roldan, et al. 2003). However, the functional relevance of these 
soluble adhesion molecules is currently unclear. Increased levels of soluble adhesion 
molecules may arise from cytokine-stimulated shedding, enzymatic cleavage, loss of 
membrane integrity, necrosis, and/or apoptosis (Pigot et al., 1992; Leeuwenbern, et al. 1992; 
Newman, et al., 1993), and may play a role in antagonizing leukocyte recruitment (Tu, et al. 
2001) or promote leukocyte recruitment through the formation of cellular aggregates. 
Ultimately, additional mechanistic studies will be required in order to pinpoint the functions 
of these soluble forms in vivo. 
4. Leukocyte migration into aortas 
4.1 Monocytes 
4.1.1 Monocyte homing to the aortic wall 
Monocytes play a key role in atherosclerosis (reviewed in (Galkina & Ley, 2009; Hansson & 
Hermansson, 2011)). Monocytes migrate into the sub-endothelial space of the aortic intima, 
where they differentiate into M (Gerrity and Naito, 1980; Jonasson et al., 1986), and 
dendritic cells (Bobryshev and Lord, 1998). Although it has not been shown directly, some 
data suggest that environmental signals within the blood and aortas determine the 
differentiation programs that give rise to M or dendritic cells in the aorta. Monocyte 
accumulation is progressive and proportional to the extent of atherosclerosis (Swirski et al., 
2006). Monocyte-derived cells are found in both the aortic adventitia and in atherosclerotic 
lesions. Similar frequencies of adoptively transferred allelic CD45 isoform monocytes and 
recipient monocytes were found within the carotid lesions, but not the adventitia of 
recipients; suggesting that M-derived foam cells arise mainly from blood-derived 
monocytes rather than resident M (Lessner et al., 2002). Whether or not adventitial M 
include a self-renewing pool remains unclear. The spleen can also serve as a reservoir of 
monocytes (Swirski et al., 2009). The role of splenic monocytes in atherosclerosis remains to 
be determined.  
P-selectin was one of the first adhesion molecules that clearly showed its involvement in 
monocyte recruitment into the aorta. Blockade of P-selectin resulted in reduced monocyte 
rolling and attachment to the carotid endothelium (Ramos et al., 1999). Further experiments  
demonstrated that P-selectin deficiency caused a decrease in fatty streaks and reduction in 
M numbers within the plaques (Table I). E-selectin expression is elevated within 
atherosclerotic aortas, and E-selectin deficiency causes slightly reduced plaque burden 
(Collins et al., 2000). There is a functional overlap between E-selectin and P-selectin as 
combined deficiency in E- and P-selectin decreases atherosclerosis by 80% (Dong et al., 
1998). Recently, a potential role for 2 and 3 integrins and an intracellular protein- 
thrombopspondin (TSP)-4 in monocyte migration was proposed. Deficiency in TSP-4 lead to 
reduced number of lesional M, and decreased 2 and 3 integrin-dependent M adhesion 
and migration in vitro (Frolova et al., 2010). 
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VCAM-1 is a central adhesion molecule that supports slow rolling and tight adhesion of 
monocytes to the atherosclerotic endothelium. Blockade of VCAM-1 or 4 integrins 
resulted in increased rolling velocity and attenuated adhesion of monocytes in ex vivo 
models of isolated perfused carotid arteries (Huo et al., 2000; Ramos et al., 1999). Blockade 
of 4 integrin using blocking Abs showed reduced influx of M into plaques (Patel et al., 
1998). Since VCAM-1-deficient mice are not viable, mice in which the fourth Ig domain of 
VCAM-1 was disrupted (Vcam-1D4D/D4D) were generated (Cybulsky et al., 2001). Reduced 
levels of VCAM-1 resulted in the reduction of atherogenesis in Vcam1D4D/D4DLdlr-/- mice 
(Cybulsky et al., 2001). VCAM-1 levels affect plaque formation, since Vcam-1D4D/+Apoe-/- 
mice showed a gene-dosage dependent influx of monocytes and plaque burden (Dansky 
et al., 2001).  
Evidence suggests that several arrest chemokines expressed on the endothelium initiate 
integrin activation and firm leukocyte adhesion. CXCL1 (Huo et al., 2001) and CCL5 (Huo et 
al., 2003) either alone or as a heterodimer with CXCL4 (von Hundelshausen et al., 2005) 
have been discovered as aortic arrest chemokines for monocyte adhesion. CXCL1 and CCL5 
and their receptors CXCR2 and CCR5 promote monocyte arrest on the atherosclerotic 
endothelium in the flow chamber system (Huo et al., 2001; Huo et al., 2003; Weber et al., 
1999). CXCL7 also efficiently triggers monocyte arrest to the inflamed endothelium under 
flow conditions (Baltus et al., 2005). Migration inhibitory factor (MIF) regulates monocyte 
arrest via the interaction of the CXCR2/CD74 complex expressed on monocytes with MIF-
expressing atherosclerotic endothelium (Bernhagen et al., 2007). Additionally, MIF 
deficiency or the blockade of MIF with anti-MIF Abs resulted in reduced lipid deposition, 
intimal thickening and M infiltration in the aorta (Pan et al., 2004; Burger-Kentischer et al., 
2006). 
CCL2 is one of the key chemokines in monocyte biology. Classical CCR2+ monocytes exit 
the bone marrow in a CCL-2-dependent manner,  and both CCL2 and CCL7 maintain 
monocyte homeostasis in the circulation (Serbina & Pamer, 2006; Tsou et al., 2007). Several 
studies suggest that the CCL2/CCR2 axis participates in atherogenesis by the modulation 
of monocyte recruitment into the aorta  (Boring et al., 1998; Dawson et al., 1999; Gosling et 
al., 1999; Gu et al., 1998). Interestingly, since CCL2 has no effects on monocyte arrest on 
the early atherosclerotic endothelium (Huo et al., 2001), CCL2 may function as a regulator 
of monocytes egress from bone marrow or chemokine that regulates monocyte 
transmigration. 
Deficiency of JAM-A reduces monocyte arrest and transmigration on activated JAM-A-
deficient endothelial cells under flow conditions in vitro, and attenuates neointimal 
formation (Zernecke et al., 2006). In line with this notion, JAM-A is involved in monocyte 
adhesion to isolated perfused Apoe-/- carotid arteries (Ostermann et al., 2005). JAM-C 
blockade decreases neointimal M content and reduces neointimal hyperplasia 
indicating a potential role of JAM-C in the regulation of monocyte transmigration 
(Shagdarsuren et al., 2009). Inactivation of ESAM-1 leads to diminished transmigration 
of THP-1 cells in in vitro assays, and ESAM-deficient Apoe-/- mice display attenuated 
atherosclerosis (Inoue et al., 2010). It is interesting that not only the adhesion molecules, 
but also one of the scavenger receptors – CD36 regulates M migration. CD36 signaling 
in response to oxLDL alters cytoskeletal dynamics and inhibits the migration of Ms. 
This may be one of the mechanisms of M accumulation in aortic lipid-rich areas (Park 







Table 1. Adhesion molecules and chemokine receptors that are involved in the recruitment 
of leukocytes into the aortic wall. (Adapted from (Galkina & Ley, 2007)) 
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Two subsets of human monocytes representing CD14high and CD14+CD16+ cells have been 
described (Passlick et al., 1989), and a new additional subset of CD14dim human monocytes 
that patrols blood vessels has been added (Cros et al., 2010). Similarly, there are two distinct 
subsets of blood circulating murine monocytes: Ly6Chigh/CCR2+/CX3CR1low inflammatory 
monocytes and Ly6Clow/CCR2-/CX3CR1high monocytes (Geissmann et al., 2003). Both 
circulate through lymphoid and non-lymphoid organs under homeostatic conditions 
(Geissmann et al., 2003; Tacke et al., 2007). Hypercholesterolemia induces monocytosis in 
Apoe-/- mice with a predominant increase in the numbers of Ly6Chigh monocytes (Swirski et 
al., 2007; Tacke et al., 2007). As different repertoires of chemokine receptors and adhesion 
molecules are expressed by each monocyte subset, these cells use different mechanisms to 
traffic into the aorta. Ly6Clow monocytes enter the atherosclerotic wall in a CCR5-dependent 
manner, but do not require CX3CR1 or CCR2 (Tacke et al., 2007). Surprisingly, 
Ly6Chigh/CCR2+ monocytes require not only CCR2, but also CX3CR1 and CCR5 for their 
recruitment into the aorta (Tacke et al., 2007). Monocyte subsets also differently express 
several adhesion molecules, which can affect their homing capacity. L-selectin is expressed 
by Ly6Chigh monocytes and likely provides primary and secondary capture of monocytes to 
the endothelium. Ly6Clow monocytes express low levels of L-selectin and CD54, but elevated 
levels of CD43 (Sunderkotter et al., 2004). Endothelial E-selectin may provide initial rolling 
of Ly6Clow monocytes on endothelium. Further understanding of the pathways that govern 
the recruitment of monocyte subsets into atherosclerotic aorta is crucial to advance our 
efforts to reduce the frequency of aortic pro-inflammatory monocytes/macrophages and 
thus, further aortic chronic inflammation. 
4.1.2 Egress of macrophages and dendritic cells from atherosclerotic aortas 
Elevated levels of monocyte-derived cells in atherosclerotic plaques could be the result of 
several processes including: 1) hyperlipidemia-induced monocytosis and increased 
monocyte recruitment, 2) increased proliferation, 3) altered balance of 
survival/apoptosis/clearance, 4) attenuated egress from the aorta. Evidence suggests that 
reduced numbers of plaque MFs orchestrate the regression of atherosclerosis repression; 
however, the cellular and molecular mechanisms underlying this process are not well 
understood. One of the first studies that focused on the potential mechanisms of M and 
dendritic cell egress from atherosclerotic plaques were performed using a surgical model 
of plaque regression. In this model, plaque-bearing aortas from Apoe-/- donor mice were 
transplanted into C57BL/6 mice with low levels of circulating cholesterol, such that the 
surgically transferred segment became a functional segment of the recipient's aorta 
(Llodra et al., 2004). Significant migration of CD68+ cells out of the plaque was detected in 
C57BL/6 recipients, whereas little emigration was detected from progressive plaques in 
Apoe-/- recipients (Llodra et al., 2004). Further experiments determined a role of the 
chemokine receptor CCR7 (Trogan et al., 2006). Liver X receptor ǂ (LXR) and LXR— are 
nuclear hormone receptors that play key roles in maintaining cholesterol homeostasis in 
M, primarily by regulating multiple components of the reverse cholesterol transport 
pathway (Bradley & Tontonoz, 2005). Interestingly, emigrated CD68+ cells expressed LXRǂ 
mRNA in foam cells in the regression environment (Trogan et al., 2006). LXR increases 
expression of CCR7 on CD68+ cells, and thus supports CCR7-dependent regression of 






HDL on aortic Mφ egress were observed in a model of atherosclerosis regression. 
Transplantation of advanced atherosclerotic segments from Apoe-/- donors to recipient 
mice bearing different levels of HDL cholesterol levels revealed that normalization of 
HDL decreases plaque burden and emigration of CD68+ cells from aortas. Thus, these 
data establish that HDL can serve as a regulator of in vivo egress of CD68+ cells from the 
plaque (Feig et al., 2011). It is likely that the balance of “In and Out” processes regulates 
M and dendritic cells cellularity in the plaque. New data also suggest that normalization 
of cholesterol can correct monocyte recruitment into the aorta and additionally, lead to 
decreased M content in atherosclerotic aortas. Treatment of Apoe-/- with apoE-encoding 
adenoviral vectors induced plaque regression, and attenuated CCR7-independent aortic 
M content (Potteaux et al., 2011). Thus, interfering with monocyte recruitment into and 
possible egress from atherosclerotic plaques may be therapeutically beneficial, in parallel 
with aggressive lipid lowering therapies, to maintain and reinforce the reduction in 
monocyte recruitment to the aorta. 
 
 
Fig. 2. Mechanisms of leukocyte recruitment in atherosclerosis 
Different steps of the adhesion cascade and adhesion molecules control the recruitment of 
leukocytes to atherosclerotic plaques. The aortic adventitia, elastic laminia, smooth muscle, 
endothelial layers, as well as tertiary lymphoid aggregates and vasa vasorum are shown. The 
adhesion proteins and chemokines involved in the rolling and tethering (1), arrest and firm 
adhesion (2), and transmigration (3) of leukocytes to the endothelium are shown. Factors that 
play a role in the recruitment of leukocyte subsets in atherogenesis are denoted by question 
marks. While neutrophils and monocytes are known to be recruited from the lumen, it is not 
clear if NK, NKT, and mast cells are recruited from the lumen as well.  
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4.2 T cell recruitment 
4.2.1 Naive and effector T cell homing 
Initially T cells were found within human atherosclerotic plaques, predominantly in the 
regions of fibrous cap (Jonasson et al., 1986). Interestingly, CD8+ T cells were almost as 
frequent as CD4+ T cells in the plaques; this differs from the CD4/CD8 ratio normally seen 
in the blood or other peripheral lymphoid tissue (Jonasson et al., 1986). Even at the earlier 
stages of atherogenesis, activated T cells have been discovered within the intimal fatty 
streaks of the human aortic wall (Munro et al., 1987). Importantly, T cells were also 
detected in non-diseased young aortas (Wick et al., 1997). Leukocytes are distributed at 
the site-specific areas around the ostia of intercostal arteries of grossly normal aorta 
(Kishikawa et al., 1993). T cells also reside in the aortic adventitia of C57BL/6 (Galkina et 
al., 2006) and Apoe-/- mice (Galkina et al., 2006; Moos et al., 2005). Adoptive transfer of T 
cells into C57BL/6 mice revealed that T cells preferentially migrate into the aortic 
adventitia and to a lesser extent into the aortic layers of normal aortas. Indirect evidence 
suggests that T cell migration occurs likely through the vasa vasorum (Galkina et al., 
2006). T cells also preferentially migrate into the adventitia of Apoe-/- mice, indicating that 
T cells use similar routes of homing to the atherosclerotic and healthy aorta (Galkina et al., 
2006).  
There are many examples of tissue-specific sets of adhesion molecules that provide selective 
recruitment (reviewed in (Ley et al., 2007)). Little is known about lymphocyte recruitment 
into the aorta, and it is unclear whether a specific set of adhesion molecules and chemokines 
are responsible for the influx of the different types of leukocytes into healthy and 
atherosclerosis-prone aortas. At least one of the selectins, L-selectin, supports the migration 
of T cells into the aorta (Galkina et al., 2006). L-selectin might not only directly interact with 
aortic endothelium, but rather provide secondary capture through L-selectin/PSGL-1 
interactions (Eriksson et al., 2001; Kunkel et al., 1998). In support of this notion, L-selectin-
dependent secondary capture was observed by intravital microscopy in the femoral artery 
and abdominal aorta (Eriksson et al., 2001).  
Evidence demonstrates that different subsets of T cells, including naïve, Tregs, Th1 and 
Th17 cells are present within the atherosclerotic aortas. Although we are still far from 
understanding how these different populations accumulate in aortas, some mechanistic 
details have been already shown. CCL5 is expressed on the luminal surface of carotid 
arteries, and platelet-dependent CCL5 deposition has been reported (Huo et al., 2003; 
von Hundelshausen et al., 2001). Deficiency in CCR5 reduced aortic CD4+ cells in parallel 
with attenuated atherosclerosis in Ccr5-/-Apoe-/- mice (Braunersreuther et al., 2007), 
indicating the importance of the CCL5/CCR5 axis for T cell migration into aortas. Naïve 
T cells express CCR7, which plays important functions in T cell recruitment into 
secondary lymphoid tissues and sites of inflammation. Importantly, CCR7 deficiency 
attenuates atherosclerosis via the regulation of T cell egress (Luchtefeld et al., 2010). The 
ligand for CCR7, CCL19 is expressed by SMCs and M in the plaques (Reape et al., 
1999). CXCL9, CXCL11 (Mach et al., 1999; Ranjbaran et al., 2006), and  CXCL12 (Bi-
Younes et al., 2000), are also detected in the lesions. CXCL10 and CXCL9 mediate the 
CXCR3-dependent rapid shear-resistant arrest of T cells on stimulated EC (Piali et al., 
1998). It was also shown that CXCL10 participates in T cell homing into atherosclerotic 






CXCL16 is detected in human and mouse atherosclerosis-prone tissues and serves in the 
membrane-bound form as a scavenger receptor and in the soluble form as a chemokine. 
CXCL16 protects against atherosclerosis, likely through a benefit of CXCL16 as a scavenger 
receptor (Aslanian and Charo, 2006). Subsets of TEFF cell express CXCR6, a chemokine 
receptor for CXCL16 (Matloubian et al., 2000). The absence of CXCR6 in Cxcr6-/-Apoe-/- mice 
leads to reduced homing of CXCR6+ T cells into atherosclerotic aortas (Galkina et al., 2007). 
CXCR2 and CXCR4 were recently identified as functional receptors for macrophage 
migration inhibition factor (MIF) (Bernhagen et al., 2007b). Blockade of MIF resulted in a 
diminished number of monocytes/M and T cells within the aortas.  
Tregs play an important role in the maintenance of the immunological tolerance (review in 
(Sakaguchi et al., 2008)). Induction of a regulatory T cell type 1 (Treg type 1) responses and 
adoptive transfer of naturally arising CD4+CD25/+ T regs reduce atherosclerosis in Apoe-/- 
mice (Mallat et al., 2003; Ait-Oufella et al., 2006). Foxp3+ cells in human atherosclerotic 
lesions colocalize with the Treg-associated chemokine receptor CCR4 and its ligand, CCL17 
(Heller et al., 2006). The molecular mechanisms that regulate homing of Treg cells into 
aortas are not well understood. 
Th17 cells are a new lineage of CD4+ T cells that play important roles in acute inflammation and 
autoimmune diseases (Bettelli et al., 2007). Expression of CCR6 and CCR4 characterizes a 
unique subset of IL-17+ human peripheral blood T cells (Costa-Rodriguez et al., 2007). Th17 cells 
also express homeostatic CCR7 and CXCR5 and share some chemokine receptors with other T 
cell lineages. Although IL-17A+ cells are less abundant than Th1 cells, IL-17A+ T cells are present 
in both atherosclerotic human and mouse arteries. While the mechanisms of Th17 cell homing 
into aortas are unclear, some ligands such as CCL2, CCL20, and CCL21 are expressed within 
the plaques and could be used by Th17 and other IL-17+ cells to home to aortas.  
4.3 B cell influx 
In 1981, B cells were discovered within the adventitia (Parums & Mitchinson, 1981), and 
immunoglobulin-positive cells were detected within the subendothelial intima of 
atherosclerotic and non-atherosclerotic rabbits (Hansson et al., 1980). CD22+ B cells were 
also detected in atherosclerotic plaques of Apoe-/- mice (Zhou & Hansson, 1999). B cells 
reside in the adventitia of C57BL/6 aortas as a consequence of constitutive L-selectin-
dependent homing to the aorta (Galkina et al., 2006). The phenotype of B cells within the 
aorta and surrounding adventitia is unclear, and further studies are needed to 
characterize adhesion molecule and chemokine receptor repertoire of aortic B cells. 
Recently, a role for smooth muscle cells (SMCs) in the regulation of lymphocyte homing 
was suggested. SMCs induce the production of CCL7, CCL9, CXCL13, CCL19, CXCL16, 
VCAM-1, and ICAM-1 (Lotzer et al., 2010). Supernatants of TNF receptor superfamily 
member 1A (TNFR-1) and LT-receptor-activated SMC markedly supported migration of 
B cells in vitro (Lotzer et al., 2010). It remains unclear whether elevated levels of 
endothelial homeostatic chemokines lead to accelerated recruitment of B cells into 
atherosclerosis–prone vessels.  
4.4 Neutrophil recruitment in atherosclerosis 
Despite a clear association between neutrophilia, neutrophil activation, and coronary artery 
disease (Baetta & Corsini, 2010; Mazzone et al., 1993), neutrophils are relatively low in 
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abundance within human atherosclerotic plaques (Baetta & Corsini, 2010). While 
neutrophils in atherosclerosis have been understudied to date, several lines of evidence 
suggest that neutrophil recruitment occurs during atherogenesis. CXCR4 and its ligand 
CXCL12 are involved in the efflux of neutrophils from bone marrow and in the regulation of 
neutrophil recruitment to atherosclerotic plaques (Zernecke et al., 2008). In addition, 
neutrophils were shown to adhere to the endothelium on the shoulder regions of 
atherosclerotic plaques (Rotzius et al., 2010). CXCR4 blockade-induced neutrophilia resulted 
in elevated plaque neutrophil content. In addition, as neutrophil chemotaxis to 
atherosclerotic plaques was impaired in CCR1, CCR2, CCR5, and CXCR2 deficient Apoe-/- 
mice, CCL2 and platelet-derived CCL5 supported neutrophil recruitment to carotid arteries. 
Based on several studies, neutrophils might migrate to developing plaques in a CCR1- and 
CCR5-dependent manner where they participate in promoting atherogenesis by supporting 
monocyte recruitment (Soehnlein et al., 2009) and inflammation (Nicholls & Hazen, 2009).  
4.5 Mast cells in atherogenesis 
While vascular mast cells are rare, they are nonetheless present within the adventitia and 
shoulder regions of atherosclerotic plaques (Lindstedt et al., 2007). Mast cell deficient KitW-
sh/W-sh mice display alterations in ApoE and ApoAII-dependent cholesterol efflux (Lee et al., 
2002). Interestingly KitW-sh/W-sh mice on the Ldlr-/- background demonstrated increased 
collagen content, fibrous cap development and reduced plaque T cell and M  cellularity 
(Sun et al., 2007). Mast cell activation correlated with M and endothelial cell apoptosis, 
vascular leakage, CXCR2 and VLA-4-mediated recruitment of leukocytes to atheroma (Bot, 
et al., 2007). Mast cells play a pro-inflammatory role in atherogenesis; however, little is 
known about the recruitment of mast cells during atherosclerosis. Lesional mast cells 
express CCR3, suggesting that mast cells may utilize eotaxin, which is expressed by vascular 
smooth muscle cells, to migrate toward atherosclerotic plaques (Haley et al., 2000).  
4.6 Natural killer (NK) cell recruitment in atherogenesis  
NK cells are found within the shoulder regions of early and advanced human 
atherosclerotic lesions. While there is currently no NK-deficient mouse model of 
atherosclerosis, there are several lines of evidence to suggest that NK cells play a role 
during atherosclerosis (reviewed in Galkina & Ley, 2007, 2009). However, little is known 
about NK cell recruitment during atherogenesis. NK cells express a variety of adhesion 
molecules, including L-selectin, PSGL-1, ǃ2 and ǂ4 integrins, and chemokine receptors, 
including CXCR3, CCR2, and CX3CR1 (Galkina & Ley, 2007). Further studies are 
necessary. Further studies are necessary to identify the players in the migration cascade of 
NK cells to atherosclerotic aortas.  
4.7 Natural killer T (NKT) cell recruitment in atherogenesis  
Several lines of evidence support the pro-atherogenic nature of NKT-cells during the 
development of atherosclerosis in both humans and mice (Galkina and Ley, 2009). As 
glycolipid antigens can be presented by CD1 to CD1-restricted T cells, NKT cells possibly 
play an important role in responding to lipid antigen presentation within the aortic wall. 
NKT cells express receptors for inflammation-related chemokines, including CCR2, CCR5, 
CXCR3, and CXCR6 and CCL2. Thus, NKT cells likely use CCL5, CXCL9-11 and CXCL16 






5. Leukocyte recruitment during experimental atherosclerosis: Luminal 
“inside-out” migration vs extra-luminal “outside-in” recruitment 
Traditionally, leukocyte migration during atherosclerosis has been considered to occur in an 
“inside-out” manner, focusing on monocyte adhesion to the endothelium on the luminal 
side of the artery and transmigration through the endothelium to arrive at the developing 
atherosclerotic plaque. Several lines of evidence support this model. Rolling and firm 
adherence of monocytes to the endothelium was demonstrated to occur in ex vivo carotid 
artery adhesion models as well as in vivo models (reviewed in (Galkina & Ley, 2007b; 
Zernecke and Weber, 2010)). However at present, there is no direct intravital microscopic 
evidence to support direct lymphocyte recruitment from the arterial lumen. Adoptive 
transfers of lymphocytes into Apoe-/- mice demonstrated that lymphocytes accumulate 
within the associated arterial adventitia suggesting a possible route of migration via 
adventitial vasa vasorum. Interestingly, the inhibition of plaque neovascularisation reduces 
M accumulation and the progression of advanced atherosclerosis (Moreno et al., 2006). 
Recent studies have also revealed that the vasa vasorum can penetrate the media, enter 
atheroma, and come close to the arterial lumen (Moreno et al., 2006; Ritman & Lerman, 2007; 
Mulligan-Kehoe, 2010). Furthermore, administration of growth factors in acid gelatine 
hydrogel microspheres around the periaortic area in 10-11 week old male Apoe-/- mice 
strongly promoted vasa vasorum neovascularisation of the aorta and corresponded with 
larger atherosclerotic plaques (Tanaka et al., 2011). Recently three studies have further 
implicated adventitial inflammation in the pathogenesis of atherosclerosis. Several reports 
have demonstrated that T and B cell aggregates accumulate within the aortic adventitia in 
atherosclerotic aortas (Galkina et al., 2003; Moos et al., 2005; Zhao et al., 2004). LTǃ was 
required for the formation of aortic tertiary lymphoid organs within the adventitia (Grabner, 
et. al. 2009). Interestingly, these tertiary lymphoid structures were characterized by distinct 
clusters of germinal centers, proliferating T cells, and elevated production of the 
lymphorganogenic chemokines CXCL13 and CCL21. Mechanistic experiments utilizing LTǃ-
receptor deficient smooth muscle cells revealed that TNF-ǂ and LTǃ-dependent activation of 
the NF-κB pathway was sufficient to induce the expression of multiple chemokines, 
including CCL2, CCL5, CXCL1, CX3CL1, CCL7, CCL9, CXCL13, CCL19, and CXCL16 
(Lötzer, et al. 2010). Together, these studies suggest that the adventitia plays an important 
structural role as the site of antigen presentation. In addition, neovascularisation from the 
adventitia to the arterial medial layer may provide a route of access for adventitial 
leukocytes to migrate to the media. Further studies will be necessary to truly determine the 
spatio-temporal relationship between the vasa vasorum, aortic tertiary lymphoid structures, 
and atherogenesis; and how these activities relate to leukocyte recruitment. 
6. Conclusions 
Our understanding of the mechanisms of leukocyte recruitment during atherogenesis has 
progressed notably since the early 1980s. The mechanisms of monocyte subset migration 
have been thoroughly studied; however, there are still many fundamental questions that 
remain to be investigated. To date, it is unclear what mechanisms are responsible for the 
recruitment of neutrophils, B cells, mast cells, NKT and NK cells into the aorta. In addition, 
while the recruitment of monocytes and neutrophils has been demonstrated to occur in an 
arterial lumen-to-plaque fashion, the directions of lymphocyte and mast cell recruitment in 
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atherogenesis has yet to be defined. While several studies have highlighted the importance 
of the vasa vasorum and adventitial lymphoid structures, the effects of these anatomical 
structures on leukocyte recruitment have yet to be explored. With progress in tissue-specific 
drug targeting, one potential alternative approach to halting the progression of 
atherosclerosis would be to develop blocking agents against crucial adhesion molecules 
within the aorta that play critical roles in aoritc leukocyte recruitment at the different stage 
of atherosclerosis.  
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